Listen to the Episode Below (00:46:00)
621: The CFO as Enabler of Science | Ivor Macleod, CFO, Athersys
When veteran CFO Ivor Macleod first contemplated joining an early-stage pharma company, the condition known as acute respiratory distress syndrome (ARDS) was not appearing in nightly news headlines and was yet to be ranked as the number one cause of death among COVID-19 patients. Nevertheless, ARDS captured his attention—or rather, Athersys did. The Cleveland, Ohio–based…